Study is first of its kind to compare diagnostic rates across short- and long-read sequencing platforms
MENLO PARK, Calif. and STAMFORD, Conn., Aug. 7, 2023 /PRNewswire/ -- PacBio (Nasdaq:PACB), a leading developer of high-quality, highly accurate sequencing solutions and GeneDx (Nasdaq:WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced a research collaboration with the University of Washington to study the capabilities of HiFi long-read whole genome sequencing (WGS) to increase diagnostic rates in pediatric patients with genetic conditions.
Read more at prnewswire.com